Alambatang, Noel H.
HRN: 25-80-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/30/2024
09/06/2024
IV
500mg
Q8h
ACUTE TONSILLOPHARYNGITIS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes